WallStreetZenWallStreetZen

NASDAQ: COGT
Cogent Biosciences Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cogent Biosciences earnings were -$269.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest COGT earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$72.0M, up 6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, COGT reported annual earnings of -$255.9M, with 33% growth.

COGT earnings history

Current Revenue
$0.0
Current Earnings
-$269.5M
Current Profit Margin
0%

COGT Return on Equity

Current Company
-92.7%
Current Industry
-60.2%
Current Market
31.5%
COGT's Return on Equity (-92.7%)... subscribe to Premium to read more.
High Return on Equity Performance

COGT undefined

Current Company
-75.6%
Current Industry
-2.5%
COGT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when COGT announces earnings.

COGT undefined

Current Company
-114.93%
Current Industry
5.8%
COGT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

COGT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
COGT-$265.07M-$269.50MN/A-$1.84
IMNM-$202.55M-$205.11MN/A-$3.18
AVBP-$127.46M-$127.46MN/A-$3.77
LENZ-$47.65M-$47.74MN/A$0.44
GHRS-$41.08M-$42.11MN/A-$0.79
View Top Biotech Stocks

Cogent Biosciences Earnings Reports & History FAQ

What were Cogent Biosciences's earnings last quarter?

On COGT's earnings call on Invalid Date, Cogent Biosciences (NASDAQ: COGT) reported Q1 2025 earnings per share (EPS) of -$0.52, up 6.12% year over year. Total COGT earnings for the quarter were -$71.99 million. In the same quarter last year, Cogent Biosciences's earnings per share (EPS) was -$0.49.

If you're new to stock investing, here's how to buy Cogent Biosciences stock.

Is Cogent Biosciences profitable or losing money?

As of the last Cogent Biosciences earnings report, Cogent Biosciences is currently losing money. Cogent Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$269.50 million, a 27.02% increase year over year.

What was COGT's earnings growth in the past year?

As of Cogent Biosciences's earnings date in Invalid Date, Cogent Biosciences's earnings has grown year over year. COGT earnings in the past year totalled -$269.50 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.